Oct. 21, 2011 | Vol. 3 No. 42
Generic-drug maker Qualitest Pharmaceuticals announced its third packaging-related recall this year after discovering that blister packaging for eight generic contraceptives obscured expiration dates.
SRI Surgical failed to adequately validate its sterilization process for making medical devices, a Form 483 states.
The U.S. Food and Drug Administration (FDA) says continued evidence of systemic good manufacturing practice (GMP) problems in overseas inspections may mean drugmakers have to apply pressure on foreign partners to maintain quality.
Pharmaceutical firm MSD is to cut 40 jobs from its Irish workforce.
Pharmaceutical giant GlaxoSmithKline is cutting about 60 jobs in Quebec City, the Canadian Union of Public Employees said.
About 50 people fell sick following emission of gas from a pharmaceutical factory at Hasnabad Bashundhara Riverview area of South Keraniganj, Bangladesh.
At the University of Maryland School of Pharmacy, scientists are working on a database that will help drug makers decide which of 1,000 or so materials are safest and most effective to deliver specific medications.
The Sri Lankan government has decided to set up facilities to manufacture pharmaceuticals locally to meet the country’s growing demand.
Hikma Pharmaceuticals has opened new Al Dar Al Arabia Pharmaceutical Manufacturing Company in Algeria, which is said to be Hikma ’s second venture in Algeria.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.